Cancer

Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expanded IP & Commercialization Opportunities

Rakuten Medical's light-activatable IR700 dye is a clinically validated component used in the approved medicine Akalux™With hydrophilicity and low toxicity1,…

3 weeks ago

Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science

Abcam has joined an industry-academic partnership led by the Structural Genomics Consortium and Pfizer to advance AI-driven drug discovery through…

3 weeks ago

Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science

Abcam has joined an industry-academic partnership led by the Structural Genomics Consortium and Pfizer to advance AI-driven drug discovery through…

3 weeks ago

Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science

Abcam has joined an industry-academic partnership led by the Structural Genomics Consortium and Pfizer to advance AI-driven drug discovery through…

3 weeks ago

HT Vet’s VISTA iQ™ Introduces New Cancer Diagnostic Service, Unlocking $130K in Annual Revenue for Veterinary Clinics

Clinics equipped with the scanner hold the key to early cancer detection for dogs, lowering costs for pet owners and…

3 weeks ago

HT Vet’s VISTA iQ™ Introduces New Cancer Diagnostic Service, Unlocking $130K in Annual Revenue for Veterinary Clinics

Clinics equipped with the scanner hold the key to early cancer detection for dogs, lowering costs for pet owners and…

3 weeks ago

HT Vet’s VISTA iQ™ Introduces New Cancer Diagnostic Service, Unlocking $130K in Annual Revenue for Veterinary Clinics

Clinics equipped with the scanner hold the key to early cancer detection for dogs, lowering costs for pet owners and…

3 weeks ago

Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis

The DROP-FPF trial is the first Phase 3 trial in interstitial lung disease (ILD) to use automated, quantitative high-resolution CT scan…

3 weeks ago

Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis

The DROP-FPF trial is the first Phase 3 trial in interstitial lung disease (ILD) to use automated, quantitative high-resolution CT scan…

3 weeks ago

Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis

The DROP-FPF trial is the first Phase 3 trial in interstitial lung disease (ILD) to use automated, quantitative high-resolution CT scan…

3 weeks ago